NT5DC3 and type 2 diabetes mellitus: The expression of NT5DC3 in blood samples could effectively distinguish patients with T2DM or T2DM-induced colon cancer from healthy volunteers, and its level was shown to be regulated by WTAP via m6A modification (41).